Global Bacterial Vaccines for Humans Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Bacterial Vaccines for Humans market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A bacterial vaccine is a type of vaccine used to prevent infections caused by bacteria. This type of vaccine works by stimulating the immune system to produce an immune response to a specific bacterium, thereby increasing the body's resistance to that bacterium. Bacterial vaccines usually contain killed or weakened bacteria, their isolated antigens, or their synthesized proteins.
The Global Info Research report includes an overview of the development of the Bacterial Vaccines for Humans industry chain, the market status of Hospital (Meningococcal Vaccine, Hib Vaccine), Clinic (Meningococcal Vaccine, Hib Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Bacterial Vaccines for Humans.
Regionally, the report analyzes the Bacterial Vaccines for Humans markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Bacterial Vaccines for Humans market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Bacterial Vaccines for Humans market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Bacterial Vaccines for Humans industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Meningococcal Vaccine, Hib Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Bacterial Vaccines for Humans market.
Regional Analysis: The report involves examining the Bacterial Vaccines for Humans market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Bacterial Vaccines for Humans market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Bacterial Vaccines for Humans:
Company Analysis: Report covers individual Bacterial Vaccines for Humans manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Bacterial Vaccines for Humans This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Bacterial Vaccines for Humans. It assesses the current state, advancements, and potential future developments in Bacterial Vaccines for Humans areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Bacterial Vaccines for Humans market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Bacterial Vaccines for Humans market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Bacterial Vaccines for Humans product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bacterial Vaccines for Humans, with price, sales, revenue and global market share of Bacterial Vaccines for Humans from 2019 to 2024.
Chapter 3, the Bacterial Vaccines for Humans competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacterial Vaccines for Humans breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Bacterial Vaccines for Humans market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bacterial Vaccines for Humans.
Chapter 14 and 15, to describe Bacterial Vaccines for Humans sales channel, distributors, customers, research findings and conclusion.
A bacterial vaccine is a type of vaccine used to prevent infections caused by bacteria. This type of vaccine works by stimulating the immune system to produce an immune response to a specific bacterium, thereby increasing the body's resistance to that bacterium. Bacterial vaccines usually contain killed or weakened bacteria, their isolated antigens, or their synthesized proteins.
The Global Info Research report includes an overview of the development of the Bacterial Vaccines for Humans industry chain, the market status of Hospital (Meningococcal Vaccine, Hib Vaccine), Clinic (Meningococcal Vaccine, Hib Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Bacterial Vaccines for Humans.
Regionally, the report analyzes the Bacterial Vaccines for Humans markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Bacterial Vaccines for Humans market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Bacterial Vaccines for Humans market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Bacterial Vaccines for Humans industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Meningococcal Vaccine, Hib Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Bacterial Vaccines for Humans market.
Regional Analysis: The report involves examining the Bacterial Vaccines for Humans market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Bacterial Vaccines for Humans market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Bacterial Vaccines for Humans:
Company Analysis: Report covers individual Bacterial Vaccines for Humans manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Bacterial Vaccines for Humans This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Bacterial Vaccines for Humans. It assesses the current state, advancements, and potential future developments in Bacterial Vaccines for Humans areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Bacterial Vaccines for Humans market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Bacterial Vaccines for Humans market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Meningococcal Vaccine
- Hib Vaccine
- BCG Vaccine
- Typhoid Vaccine
- Anthrax Vaccine
- Hospital
- Clinic
- Others
- Merck
- Sanofi
- GSK
- Mitsubishi Tanabe Pharma
- Pfizer
- Bayer
- Emergent BioSolutions
- Walvax
- Chengdu Kanghua Biological Products Co., Ltd.
- Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
- Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
- Beijing Institute of Biological Products Co., Ltd.
- CanSino Biological Co., Ltd.
- Hualan Biological Vaccine Co., Ltd.
- Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Bacterial Vaccines for Humans product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bacterial Vaccines for Humans, with price, sales, revenue and global market share of Bacterial Vaccines for Humans from 2019 to 2024.
Chapter 3, the Bacterial Vaccines for Humans competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bacterial Vaccines for Humans breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Bacterial Vaccines for Humans market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bacterial Vaccines for Humans.
Chapter 14 and 15, to describe Bacterial Vaccines for Humans sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Bacterial Vaccines for Humans
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bacterial Vaccines for Humans Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Meningococcal Vaccine
1.3.3 Hib Vaccine
1.3.4 BCG Vaccine
1.3.5 Typhoid Vaccine
1.3.6 Anthrax Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Bacterial Vaccines for Humans Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Bacterial Vaccines for Humans Market Size & Forecast
1.5.1 Global Bacterial Vaccines for Humans Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Bacterial Vaccines for Humans Sales Quantity (2019-2030)
1.5.3 Global Bacterial Vaccines for Humans Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Bacterial Vaccines for Humans Product and Services
2.1.4 Merck Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Bacterial Vaccines for Humans Product and Services
2.2.4 Sanofi Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Bacterial Vaccines for Humans Product and Services
2.3.4 GSK Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments/Updates
2.4 Mitsubishi Tanabe Pharma
2.4.1 Mitsubishi Tanabe Pharma Details
2.4.2 Mitsubishi Tanabe Pharma Major Business
2.4.3 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
2.4.4 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Bacterial Vaccines for Humans Product and Services
2.5.4 Pfizer Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Bacterial Vaccines for Humans Product and Services
2.6.4 Bayer Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bayer Recent Developments/Updates
2.7 Emergent BioSolutions
2.7.1 Emergent BioSolutions Details
2.7.2 Emergent BioSolutions Major Business
2.7.3 Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
2.7.4 Emergent BioSolutions Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Emergent BioSolutions Recent Developments/Updates
2.8 Walvax
2.8.1 Walvax Details
2.8.2 Walvax Major Business
2.8.3 Walvax Bacterial Vaccines for Humans Product and Services
2.8.4 Walvax Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Walvax Recent Developments/Updates
2.9 Chengdu Kanghua Biological Products Co., Ltd.
2.9.1 Chengdu Kanghua Biological Products Co., Ltd. Details
2.9.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
2.9.3 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.9.4 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
2.10 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
2.10.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
2.10.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
2.10.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.11 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
2.11.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
2.11.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
2.11.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.11.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Beijing Institute of Biological Products Co., Ltd.
2.12.1 Beijing Institute of Biological Products Co., Ltd. Details
2.12.2 Beijing Institute of Biological Products Co., Ltd. Major Business
2.12.3 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.12.4 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
2.13 CanSino Biological Co., Ltd.
2.13.1 CanSino Biological Co., Ltd. Details
2.13.2 CanSino Biological Co., Ltd. Major Business
2.13.3 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.13.4 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 CanSino Biological Co., Ltd. Recent Developments/Updates
2.14 Hualan Biological Vaccine Co., Ltd.
2.14.1 Hualan Biological Vaccine Co., Ltd. Details
2.14.2 Hualan Biological Vaccine Co., Ltd. Major Business
2.14.3 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.14.4 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
2.15 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
2.15.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
2.15.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
2.15.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.15.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BACTERIAL VACCINES FOR HUMANS BY MANUFACTURER
3.1 Global Bacterial Vaccines for Humans Sales Quantity by Manufacturer (2019-2024)
3.2 Global Bacterial Vaccines for Humans Revenue by Manufacturer (2019-2024)
3.3 Global Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Bacterial Vaccines for Humans by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Bacterial Vaccines for Humans Manufacturer Market Share in 2023
3.4.2 Top 6 Bacterial Vaccines for Humans Manufacturer Market Share in 2023
3.5 Bacterial Vaccines for Humans Market: Overall Company Footprint Analysis
3.5.1 Bacterial Vaccines for Humans Market: Region Footprint
3.5.2 Bacterial Vaccines for Humans Market: Company Product Type Footprint
3.5.3 Bacterial Vaccines for Humans Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Bacterial Vaccines for Humans Market Size by Region
4.1.1 Global Bacterial Vaccines for Humans Sales Quantity by Region (2019-2030)
4.1.2 Global Bacterial Vaccines for Humans Consumption Value by Region (2019-2030)
4.1.3 Global Bacterial Vaccines for Humans Average Price by Region (2019-2030)
4.2 North America Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.3 Europe Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.4 Asia-Pacific Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.5 South America Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.6 Middle East and Africa Bacterial Vaccines for Humans Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
5.2 Global Bacterial Vaccines for Humans Consumption Value by Type (2019-2030)
5.3 Global Bacterial Vaccines for Humans Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
6.2 Global Bacterial Vaccines for Humans Consumption Value by Application (2019-2030)
6.3 Global Bacterial Vaccines for Humans Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
7.2 North America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
7.3 North America Bacterial Vaccines for Humans Market Size by Country
7.3.1 North America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
7.3.2 North America Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
8.2 Europe Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
8.3 Europe Bacterial Vaccines for Humans Market Size by Country
8.3.1 Europe Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
8.3.2 Europe Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Bacterial Vaccines for Humans Market Size by Region
9.3.1 Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Bacterial Vaccines for Humans Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
10.2 South America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
10.3 South America Bacterial Vaccines for Humans Market Size by Country
10.3.1 South America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
10.3.2 South America Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Bacterial Vaccines for Humans Market Size by Country
11.3.1 Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Bacterial Vaccines for Humans Market Drivers
12.2 Bacterial Vaccines for Humans Market Restraints
12.3 Bacterial Vaccines for Humans Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Bacterial Vaccines for Humans and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bacterial Vaccines for Humans
13.3 Bacterial Vaccines for Humans Production Process
13.4 Bacterial Vaccines for Humans Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bacterial Vaccines for Humans Typical Distributors
14.3 Bacterial Vaccines for Humans Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Bacterial Vaccines for Humans
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bacterial Vaccines for Humans Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Meningococcal Vaccine
1.3.3 Hib Vaccine
1.3.4 BCG Vaccine
1.3.5 Typhoid Vaccine
1.3.6 Anthrax Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Bacterial Vaccines for Humans Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Bacterial Vaccines for Humans Market Size & Forecast
1.5.1 Global Bacterial Vaccines for Humans Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Bacterial Vaccines for Humans Sales Quantity (2019-2030)
1.5.3 Global Bacterial Vaccines for Humans Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Bacterial Vaccines for Humans Product and Services
2.1.4 Merck Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Bacterial Vaccines for Humans Product and Services
2.2.4 Sanofi Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Bacterial Vaccines for Humans Product and Services
2.3.4 GSK Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GSK Recent Developments/Updates
2.4 Mitsubishi Tanabe Pharma
2.4.1 Mitsubishi Tanabe Pharma Details
2.4.2 Mitsubishi Tanabe Pharma Major Business
2.4.3 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
2.4.4 Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Bacterial Vaccines for Humans Product and Services
2.5.4 Pfizer Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Bacterial Vaccines for Humans Product and Services
2.6.4 Bayer Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bayer Recent Developments/Updates
2.7 Emergent BioSolutions
2.7.1 Emergent BioSolutions Details
2.7.2 Emergent BioSolutions Major Business
2.7.3 Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
2.7.4 Emergent BioSolutions Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Emergent BioSolutions Recent Developments/Updates
2.8 Walvax
2.8.1 Walvax Details
2.8.2 Walvax Major Business
2.8.3 Walvax Bacterial Vaccines for Humans Product and Services
2.8.4 Walvax Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Walvax Recent Developments/Updates
2.9 Chengdu Kanghua Biological Products Co., Ltd.
2.9.1 Chengdu Kanghua Biological Products Co., Ltd. Details
2.9.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
2.9.3 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.9.4 Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
2.10 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
2.10.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
2.10.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
2.10.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.10.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.11 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
2.11.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
2.11.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
2.11.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.11.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Beijing Institute of Biological Products Co., Ltd.
2.12.1 Beijing Institute of Biological Products Co., Ltd. Details
2.12.2 Beijing Institute of Biological Products Co., Ltd. Major Business
2.12.3 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.12.4 Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
2.13 CanSino Biological Co., Ltd.
2.13.1 CanSino Biological Co., Ltd. Details
2.13.2 CanSino Biological Co., Ltd. Major Business
2.13.3 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.13.4 CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 CanSino Biological Co., Ltd. Recent Developments/Updates
2.14 Hualan Biological Vaccine Co., Ltd.
2.14.1 Hualan Biological Vaccine Co., Ltd. Details
2.14.2 Hualan Biological Vaccine Co., Ltd. Major Business
2.14.3 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.14.4 Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
2.15 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
2.15.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
2.15.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
2.15.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
2.15.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BACTERIAL VACCINES FOR HUMANS BY MANUFACTURER
3.1 Global Bacterial Vaccines for Humans Sales Quantity by Manufacturer (2019-2024)
3.2 Global Bacterial Vaccines for Humans Revenue by Manufacturer (2019-2024)
3.3 Global Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Bacterial Vaccines for Humans by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Bacterial Vaccines for Humans Manufacturer Market Share in 2023
3.4.2 Top 6 Bacterial Vaccines for Humans Manufacturer Market Share in 2023
3.5 Bacterial Vaccines for Humans Market: Overall Company Footprint Analysis
3.5.1 Bacterial Vaccines for Humans Market: Region Footprint
3.5.2 Bacterial Vaccines for Humans Market: Company Product Type Footprint
3.5.3 Bacterial Vaccines for Humans Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Bacterial Vaccines for Humans Market Size by Region
4.1.1 Global Bacterial Vaccines for Humans Sales Quantity by Region (2019-2030)
4.1.2 Global Bacterial Vaccines for Humans Consumption Value by Region (2019-2030)
4.1.3 Global Bacterial Vaccines for Humans Average Price by Region (2019-2030)
4.2 North America Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.3 Europe Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.4 Asia-Pacific Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.5 South America Bacterial Vaccines for Humans Consumption Value (2019-2030)
4.6 Middle East and Africa Bacterial Vaccines for Humans Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
5.2 Global Bacterial Vaccines for Humans Consumption Value by Type (2019-2030)
5.3 Global Bacterial Vaccines for Humans Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
6.2 Global Bacterial Vaccines for Humans Consumption Value by Application (2019-2030)
6.3 Global Bacterial Vaccines for Humans Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
7.2 North America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
7.3 North America Bacterial Vaccines for Humans Market Size by Country
7.3.1 North America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
7.3.2 North America Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
8.2 Europe Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
8.3 Europe Bacterial Vaccines for Humans Market Size by Country
8.3.1 Europe Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
8.3.2 Europe Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Bacterial Vaccines for Humans Market Size by Region
9.3.1 Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Bacterial Vaccines for Humans Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
10.2 South America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
10.3 South America Bacterial Vaccines for Humans Market Size by Country
10.3.1 South America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
10.3.2 South America Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Bacterial Vaccines for Humans Market Size by Country
11.3.1 Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Bacterial Vaccines for Humans Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Bacterial Vaccines for Humans Market Drivers
12.2 Bacterial Vaccines for Humans Market Restraints
12.3 Bacterial Vaccines for Humans Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Bacterial Vaccines for Humans and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bacterial Vaccines for Humans
13.3 Bacterial Vaccines for Humans Production Process
13.4 Bacterial Vaccines for Humans Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bacterial Vaccines for Humans Typical Distributors
14.3 Bacterial Vaccines for Humans Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Bacterial Vaccines for Humans Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Bacterial Vaccines for Humans Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Bacterial Vaccines for Humans Product and Services
Table 6. Merck Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Bacterial Vaccines for Humans Product and Services
Table 11. Sanofi Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Bacterial Vaccines for Humans Product and Services
Table 16. GSK Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GSK Recent Developments/Updates
Table 18. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Mitsubishi Tanabe Pharma Major Business
Table 20. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
Table 21. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Bacterial Vaccines for Humans Product and Services
Table 26. Pfizer Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer Recent Developments/Updates
Table 28. Bayer Basic Information, Manufacturing Base and Competitors
Table 29. Bayer Major Business
Table 30. Bayer Bacterial Vaccines for Humans Product and Services
Table 31. Bayer Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bayer Recent Developments/Updates
Table 33. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 34. Emergent BioSolutions Major Business
Table 35. Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
Table 36. Emergent BioSolutions Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Emergent BioSolutions Recent Developments/Updates
Table 38. Walvax Basic Information, Manufacturing Base and Competitors
Table 39. Walvax Major Business
Table 40. Walvax Bacterial Vaccines for Humans Product and Services
Table 41. Walvax Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Walvax Recent Developments/Updates
Table 43. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 45. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 46. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 48. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
Table 50. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 51. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 53. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
Table 55. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 56. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Institute of Biological Products Co., Ltd. Major Business
Table 60. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 61. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 63. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. CanSino Biological Co., Ltd. Major Business
Table 65. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 66. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 68. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Hualan Biological Vaccine Co., Ltd. Major Business
Table 70. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 71. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 73. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
Table 75. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 76. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
Table 78. Global Bacterial Vaccines for Humans Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 79. Global Bacterial Vaccines for Humans Revenue by Manufacturer (2019-2024) & (USD Million)
Table 80. Global Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 81. Market Position of Manufacturers in Bacterial Vaccines for Humans, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 82. Head Office and Bacterial Vaccines for Humans Production Site of Key Manufacturer
Table 83. Bacterial Vaccines for Humans Market: Company Product Type Footprint
Table 84. Bacterial Vaccines for Humans Market: Company Product Application Footprint
Table 85. Bacterial Vaccines for Humans New Market Entrants and Barriers to Market Entry
Table 86. Bacterial Vaccines for Humans Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Bacterial Vaccines for Humans Sales Quantity by Region (2019-2024) & (K Units)
Table 88. Global Bacterial Vaccines for Humans Sales Quantity by Region (2025-2030) & (K Units)
Table 89. Global Bacterial Vaccines for Humans Consumption Value by Region (2019-2024) & (USD Million)
Table 90. Global Bacterial Vaccines for Humans Consumption Value by Region (2025-2030) & (USD Million)
Table 91. Global Bacterial Vaccines for Humans Average Price by Region (2019-2024) & (US$/Unit)
Table 92. Global Bacterial Vaccines for Humans Average Price by Region (2025-2030) & (US$/Unit)
Table 93. Global Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Global Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Global Bacterial Vaccines for Humans Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Global Bacterial Vaccines for Humans Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Global Bacterial Vaccines for Humans Average Price by Type (2019-2024) & (US$/Unit)
Table 98. Global Bacterial Vaccines for Humans Average Price by Type (2025-2030) & (US$/Unit)
Table 99. Global Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Global Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Global Bacterial Vaccines for Humans Consumption Value by Application (2019-2024) & (USD Million)
Table 102. Global Bacterial Vaccines for Humans Consumption Value by Application (2025-2030) & (USD Million)
Table 103. Global Bacterial Vaccines for Humans Average Price by Application (2019-2024) & (US$/Unit)
Table 104. Global Bacterial Vaccines for Humans Average Price by Application (2025-2030) & (US$/Unit)
Table 105. North America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 106. North America Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 107. North America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 108. North America Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 109. North America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2024) & (K Units)
Table 110. North America Bacterial Vaccines for Humans Sales Quantity by Country (2025-2030) & (K Units)
Table 111. North America Bacterial Vaccines for Humans Consumption Value by Country (2019-2024) & (USD Million)
Table 112. North America Bacterial Vaccines for Humans Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Europe Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Europe Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Europe Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Europe Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Europe Bacterial Vaccines for Humans Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Europe Bacterial Vaccines for Humans Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Europe Bacterial Vaccines for Humans Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Bacterial Vaccines for Humans Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 122. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 123. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 124. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 125. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Region (2019-2024) & (K Units)
Table 126. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Region (2025-2030) & (K Units)
Table 127. Asia-Pacific Bacterial Vaccines for Humans Consumption Value by Region (2019-2024) & (USD Million)
Table 128. Asia-Pacific Bacterial Vaccines for Humans Consumption Value by Region (2025-2030) & (USD Million)
Table 129. South America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 130. South America Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 131. South America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 132. South America Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 133. South America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2024) & (K Units)
Table 134. South America Bacterial Vaccines for Humans Sales Quantity by Country (2025-2030) & (K Units)
Table 135. South America Bacterial Vaccines for Humans Consumption Value by Country (2019-2024) & (USD Million)
Table 136. South America Bacterial Vaccines for Humans Consumption Value by Country (2025-2030) & (USD Million)
Table 137. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 138. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 139. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 140. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 141. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Region (2019-2024) & (K Units)
Table 142. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Region (2025-2030) & (K Units)
Table 143. Middle East & Africa Bacterial Vaccines for Humans Consumption Value by Region (2019-2024) & (USD Million)
Table 144. Middle East & Africa Bacterial Vaccines for Humans Consumption Value by Region (2025-2030) & (USD Million)
Table 145. Bacterial Vaccines for Humans Raw Material
Table 146. Key Manufacturers of Bacterial Vaccines for Humans Raw Materials
Table 147. Bacterial Vaccines for Humans Typical Distributors
Table 148. Bacterial Vaccines for Humans Typical Customers
LIST OF FIGURE
s
Figure 1. Bacterial Vaccines for Humans Picture
Figure 2. Global Bacterial Vaccines for Humans Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Bacterial Vaccines for Humans Consumption Value Market Share by Type in 2023
Figure 4. Meningococcal Vaccine Examples
Figure 5. Hib Vaccine Examples
Figure 6. BCG Vaccine Examples
Figure 7. Typhoid Vaccine Examples
Figure 8. Anthrax Vaccine Examples
Figure 9. Global Bacterial Vaccines for Humans Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Bacterial Vaccines for Humans Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Bacterial Vaccines for Humans Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Bacterial Vaccines for Humans Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Bacterial Vaccines for Humans Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Bacterial Vaccines for Humans Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Bacterial Vaccines for Humans Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Bacterial Vaccines for Humans by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Bacterial Vaccines for Humans Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Bacterial Vaccines for Humans Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Bacterial Vaccines for Humans Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Bacterial Vaccines for Humans Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Bacterial Vaccines for Humans Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Bacterial Vaccines for Humans Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Bacterial Vaccines for Humans Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Bacterial Vaccines for Humans Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Bacterial Vaccines for Humans Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Bacterial Vaccines for Humans Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Bacterial Vaccines for Humans Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Bacterial Vaccines for Humans Consumption Value Market Share by Region (2019-2030)
Figure 56. China Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Bacterial Vaccines for Humans Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Bacterial Vaccines for Humans Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Bacterial Vaccines for Humans Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Bacterial Vaccines for Humans Market Drivers
Figure 77. Bacterial Vaccines for Humans Market Restraints
Figure 78. Bacterial Vaccines for Humans Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Bacterial Vaccines for Humans in 2023
Figure 81. Manufacturing Process Analysis of Bacterial Vaccines for Humans
Figure 82. Bacterial Vaccines for Humans Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Table 1. Global Bacterial Vaccines for Humans Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Bacterial Vaccines for Humans Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Bacterial Vaccines for Humans Product and Services
Table 6. Merck Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Bacterial Vaccines for Humans Product and Services
Table 11. Sanofi Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Bacterial Vaccines for Humans Product and Services
Table 16. GSK Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. GSK Recent Developments/Updates
Table 18. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Mitsubishi Tanabe Pharma Major Business
Table 20. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Product and Services
Table 21. Mitsubishi Tanabe Pharma Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Bacterial Vaccines for Humans Product and Services
Table 26. Pfizer Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer Recent Developments/Updates
Table 28. Bayer Basic Information, Manufacturing Base and Competitors
Table 29. Bayer Major Business
Table 30. Bayer Bacterial Vaccines for Humans Product and Services
Table 31. Bayer Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bayer Recent Developments/Updates
Table 33. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 34. Emergent BioSolutions Major Business
Table 35. Emergent BioSolutions Bacterial Vaccines for Humans Product and Services
Table 36. Emergent BioSolutions Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Emergent BioSolutions Recent Developments/Updates
Table 38. Walvax Basic Information, Manufacturing Base and Competitors
Table 39. Walvax Major Business
Table 40. Walvax Bacterial Vaccines for Humans Product and Services
Table 41. Walvax Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Walvax Recent Developments/Updates
Table 43. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 45. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 46. Chengdu Kanghua Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 48. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
Table 50. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 51. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 53. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
Table 55. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 56. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Institute of Biological Products Co., Ltd. Major Business
Table 60. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 61. Beijing Institute of Biological Products Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 63. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. CanSino Biological Co., Ltd. Major Business
Table 65. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 66. CanSino Biological Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 68. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Hualan Biological Vaccine Co., Ltd. Major Business
Table 70. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 71. Hualan Biological Vaccine Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 73. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
Table 75. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Product and Services
Table 76. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Bacterial Vaccines for Humans Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
Table 78. Global Bacterial Vaccines for Humans Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 79. Global Bacterial Vaccines for Humans Revenue by Manufacturer (2019-2024) & (USD Million)
Table 80. Global Bacterial Vaccines for Humans Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 81. Market Position of Manufacturers in Bacterial Vaccines for Humans, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 82. Head Office and Bacterial Vaccines for Humans Production Site of Key Manufacturer
Table 83. Bacterial Vaccines for Humans Market: Company Product Type Footprint
Table 84. Bacterial Vaccines for Humans Market: Company Product Application Footprint
Table 85. Bacterial Vaccines for Humans New Market Entrants and Barriers to Market Entry
Table 86. Bacterial Vaccines for Humans Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Bacterial Vaccines for Humans Sales Quantity by Region (2019-2024) & (K Units)
Table 88. Global Bacterial Vaccines for Humans Sales Quantity by Region (2025-2030) & (K Units)
Table 89. Global Bacterial Vaccines for Humans Consumption Value by Region (2019-2024) & (USD Million)
Table 90. Global Bacterial Vaccines for Humans Consumption Value by Region (2025-2030) & (USD Million)
Table 91. Global Bacterial Vaccines for Humans Average Price by Region (2019-2024) & (US$/Unit)
Table 92. Global Bacterial Vaccines for Humans Average Price by Region (2025-2030) & (US$/Unit)
Table 93. Global Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Global Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Global Bacterial Vaccines for Humans Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Global Bacterial Vaccines for Humans Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Global Bacterial Vaccines for Humans Average Price by Type (2019-2024) & (US$/Unit)
Table 98. Global Bacterial Vaccines for Humans Average Price by Type (2025-2030) & (US$/Unit)
Table 99. Global Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 100. Global Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 101. Global Bacterial Vaccines for Humans Consumption Value by Application (2019-2024) & (USD Million)
Table 102. Global Bacterial Vaccines for Humans Consumption Value by Application (2025-2030) & (USD Million)
Table 103. Global Bacterial Vaccines for Humans Average Price by Application (2019-2024) & (US$/Unit)
Table 104. Global Bacterial Vaccines for Humans Average Price by Application (2025-2030) & (US$/Unit)
Table 105. North America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 106. North America Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 107. North America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 108. North America Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 109. North America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2024) & (K Units)
Table 110. North America Bacterial Vaccines for Humans Sales Quantity by Country (2025-2030) & (K Units)
Table 111. North America Bacterial Vaccines for Humans Consumption Value by Country (2019-2024) & (USD Million)
Table 112. North America Bacterial Vaccines for Humans Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Europe Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 114. Europe Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 115. Europe Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 116. Europe Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 117. Europe Bacterial Vaccines for Humans Sales Quantity by Country (2019-2024) & (K Units)
Table 118. Europe Bacterial Vaccines for Humans Sales Quantity by Country (2025-2030) & (K Units)
Table 119. Europe Bacterial Vaccines for Humans Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Bacterial Vaccines for Humans Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 122. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 123. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 124. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 125. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Region (2019-2024) & (K Units)
Table 126. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity by Region (2025-2030) & (K Units)
Table 127. Asia-Pacific Bacterial Vaccines for Humans Consumption Value by Region (2019-2024) & (USD Million)
Table 128. Asia-Pacific Bacterial Vaccines for Humans Consumption Value by Region (2025-2030) & (USD Million)
Table 129. South America Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 130. South America Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 131. South America Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 132. South America Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 133. South America Bacterial Vaccines for Humans Sales Quantity by Country (2019-2024) & (K Units)
Table 134. South America Bacterial Vaccines for Humans Sales Quantity by Country (2025-2030) & (K Units)
Table 135. South America Bacterial Vaccines for Humans Consumption Value by Country (2019-2024) & (USD Million)
Table 136. South America Bacterial Vaccines for Humans Consumption Value by Country (2025-2030) & (USD Million)
Table 137. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Type (2019-2024) & (K Units)
Table 138. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Type (2025-2030) & (K Units)
Table 139. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Application (2019-2024) & (K Units)
Table 140. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Application (2025-2030) & (K Units)
Table 141. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Region (2019-2024) & (K Units)
Table 142. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity by Region (2025-2030) & (K Units)
Table 143. Middle East & Africa Bacterial Vaccines for Humans Consumption Value by Region (2019-2024) & (USD Million)
Table 144. Middle East & Africa Bacterial Vaccines for Humans Consumption Value by Region (2025-2030) & (USD Million)
Table 145. Bacterial Vaccines for Humans Raw Material
Table 146. Key Manufacturers of Bacterial Vaccines for Humans Raw Materials
Table 147. Bacterial Vaccines for Humans Typical Distributors
Table 148. Bacterial Vaccines for Humans Typical Customers
LIST OF FIGURE
s
Figure 1. Bacterial Vaccines for Humans Picture
Figure 2. Global Bacterial Vaccines for Humans Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Bacterial Vaccines for Humans Consumption Value Market Share by Type in 2023
Figure 4. Meningococcal Vaccine Examples
Figure 5. Hib Vaccine Examples
Figure 6. BCG Vaccine Examples
Figure 7. Typhoid Vaccine Examples
Figure 8. Anthrax Vaccine Examples
Figure 9. Global Bacterial Vaccines for Humans Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Bacterial Vaccines for Humans Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Bacterial Vaccines for Humans Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Bacterial Vaccines for Humans Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Bacterial Vaccines for Humans Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Bacterial Vaccines for Humans Average Price (2019-2030) & (US$/Unit)
Figure 18. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Bacterial Vaccines for Humans Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Bacterial Vaccines for Humans by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Bacterial Vaccines for Humans Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Bacterial Vaccines for Humans Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Bacterial Vaccines for Humans Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Bacterial Vaccines for Humans Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Bacterial Vaccines for Humans Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Bacterial Vaccines for Humans Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Bacterial Vaccines for Humans Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Bacterial Vaccines for Humans Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Bacterial Vaccines for Humans Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Bacterial Vaccines for Humans Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Bacterial Vaccines for Humans Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Bacterial Vaccines for Humans Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Bacterial Vaccines for Humans Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Bacterial Vaccines for Humans Consumption Value Market Share by Region (2019-2030)
Figure 56. China Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Bacterial Vaccines for Humans Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Bacterial Vaccines for Humans Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Bacterial Vaccines for Humans Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Bacterial Vaccines for Humans Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Bacterial Vaccines for Humans Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Bacterial Vaccines for Humans Market Drivers
Figure 77. Bacterial Vaccines for Humans Market Restraints
Figure 78. Bacterial Vaccines for Humans Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Bacterial Vaccines for Humans in 2023
Figure 81. Manufacturing Process Analysis of Bacterial Vaccines for Humans
Figure 82. Bacterial Vaccines for Humans Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
